CH BIOTECH SER (08037) Schedules Board Meeting on 27 March 2026 to Review Annual Results

Bulletin Express03-06

CH BIOTECH SER (08037) has announced that its Board of Directors will hold a meeting on Friday, 27 March 2026 to consider and approve the audited consolidated annual results for the year ended 31 December 2025. The Board will also consider the payment of a final dividend, if any, during this meeting. According to the notice dated 6 March 2026, the company and its subsidiaries plan to disclose the outcome upon completion.

As of the announcement date, the Board of Directors is composed of four executive Directors, namely Chairman Liu Xiaolin, He Xun, Huang Song, and Dr. Yin Ye, as well as three independent non-executive Directors, namely Yan Guoxiang, Dr. Guo Yuantao, and Dr. Zhang Xiao.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1167023699?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167023699","market":"hk","top_or_hot":-1,"title":"CH BIOTECH SER (08037) Schedules Board Meeting on 27 March 2026 to Review Annual Results","media":"Bulletin Express","content":"<p>CH BIOTECH SER (08037) has announced that its Board of Directors will hold a meeting on Friday, 27 March 2026 to consider and approve the audited consolidated annual results for the year ended 31 December 2025. The Board will also consider the payment of a final dividend, if any, during this meeting. According to the notice dated 6 March 2026, the company and its subsidiaries plan to disclose the outcome upon completion.</p>\n<p>As of the announcement date, the Board of Directors is composed of four executive Directors, namely Chairman Liu Xiaolin, He Xun, Huang Song, and Dr. Yin Ye, as well as three independent non-executive Directors, namely Yan Guoxiang, Dr. Guo Yuantao, and Dr. Zhang Xiao.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CH BIOTECH SER (08037) Schedules Board Meeting on 27 March 2026 to Review Annual Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCH BIOTECH SER (08037) Schedules Board Meeting on 27 March 2026 to Review Annual Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-06 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CH BIOTECH SER (08037) has announced that its Board of Directors will hold a meeting on Friday, 27 March 2026 to consider and approve the audited consolidated annual results for the year ended 31 December 2025. The Board will also consider the payment of a final dividend, if any, during this meeting. According to the notice dated 6 March 2026, the company and its subsidiaries plan to disclose the outcome upon completion.</p>\n<p>As of the announcement date, the Board of Directors is composed of four executive Directors, namely Chairman Liu Xiaolin, He Xun, Huang Song, and Dr. Yin Ye, as well as three independent non-executive Directors, namely Yan Guoxiang, Dr. Guo Yuantao, and Dr. Zhang Xiao.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08037","symbol_name":"中国生物科技服务","start_time":0,"source_url":"","article_id":"1167023699","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167023699","pubTimestamp":1772802170,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CH BIOTECH SER (08037) has announced that its Board of Directors will hold a meeting on Friday, 27 March 2026 to consider and approve the audited consolidated annual results for the year ended 31...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08037":"中国生物科技服务"},"translate_title":"CH BIOTECH SER(08037)计划于2026年3月27日召开董事会审阅年度业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"CH BIOTECH SER (08037) has announced that its Board of Directors will hold a meeting on Friday, 27 March 2026 to consider and approve the audited consolidated annual results for the year ended 31 December 2025. The Board will also consider the payment of a final dividend, if any, during this meeting. According to the notice dated 6 March 2026, the company and its subsidiaries plan to disclose the outcome upon completion.\nAs of the announcement date, the Board of Directors is composed of four executive Directors, namely Chairman Liu Xiaolin, He Xun, Huang Song, and Dr. Yin Ye, as well as three independent non-executive Directors, namely Yan Guoxiang, Dr. Guo Yuantao, and Dr. Zhang Xiao.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1167023699","isCrawlerRequest":true}